$122 Million is the total value of Prosight Management, LP's 37 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 78.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Sell | PROTHENA CORP PLC | $15,072,000 | +15.0% | 600,000 | -45.0% | 12.34% | +103.8% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $8,241,000 | +20.7% | 38,350 | +32.7% | 6.75% | +113.8% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $8,190,000 | -13.3% | 100,000 | -12.5% | 6.71% | +53.6% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $7,343,000 | -34.4% | 105,828 | -27.4% | 6.01% | +16.3% |
| CUE | Sell | CUE BIOPHARMA INC | $6,793,000 | -40.1% | 556,777 | -38.6% | 5.56% | +6.1% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $6,035,000 | -42.4% | 95,600 | -43.4% | 4.94% | +2.0% |
| ALBO | Sell | ALBIREO PHARMA INC | $6,005,000 | -8.4% | 170,352 | -2.5% | 4.92% | +62.3% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $5,625,000 | -9.7% | 473,446 | -47.9% | 4.61% | +60.0% |
| GLPG | New | GALAPAGOS NVspon adr | $5,120,000 | – | 66,419 | +100.0% | 4.19% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $4,685,000 | -33.4% | 360,834 | -29.1% | 3.84% | +18.0% |
| KZR | New | KEZAR LIFE SCIENCES INC | $4,472,000 | – | 750,310 | +100.0% | 3.66% | – |
| MGTX | Sell | MEIRAGTX HLDGS PLC | $4,213,000 | -27.0% | 291,944 | -23.4% | 3.45% | +29.4% |
| ZGNX | Buy | ZOGENIX INC | $3,806,000 | +27.3% | 195,000 | +30.4% | 3.12% | +125.7% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $3,393,000 | -38.0% | 21,197 | -40.3% | 2.78% | +9.9% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $2,976,000 | +177.9% | 450,165 | +76.5% | 2.44% | +392.3% |
| OSCR | New | OSCAR HEALTH INCcl a | $2,878,000 | – | 107,086 | +100.0% | 2.36% | – |
| CLLS | New | CELLECTIS S Aspon ads | $2,787,000 | – | 137,900 | +100.0% | 2.28% | – |
| INOV | Sell | INOVALON HLDGS INC | $2,446,000 | -41.7% | 85,000 | -63.2% | 2.00% | +3.4% |
| MDT | New | MEDTRONIC PLC | $2,373,000 | – | 20,088 | +100.0% | 1.94% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $2,232,000 | – | 6,000 | +100.0% | 1.83% | – |
| CARA | Sell | CARA THERAPEUTICS INC | $2,171,000 | -51.2% | 100,000 | -66.0% | 1.78% | -13.5% |
| MTCR | Sell | METACRINE INC | $1,888,000 | -57.4% | 304,485 | -45.9% | 1.55% | -24.4% |
| SLDB | New | SOLID BIOSCIENCES INC | $1,770,000 | – | 320,100 | +100.0% | 1.45% | – |
| LHCG | Buy | LHC GROUP INC | $1,679,000 | +186.5% | 8,783 | +219.8% | 1.38% | +407.4% |
| Buy | AKUMIN INC | $1,588,000 | +135.3% | 429,061 | +91.3% | 1.30% | +316.7% | |
| BEAM | New | BEAM THERAPEUTICS INC | $1,361,000 | – | 17,000 | +100.0% | 1.11% | – |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $1,328,000 | -95.2% | 8,685 | -95.1% | 1.09% | -91.4% |
| ONCR | New | ONCORUS INC | $986,000 | – | 70,807 | +100.0% | 0.81% | – |
| Sell | APTOSE BIOSCIENCES INC | $896,000 | -75.2% | 150,000 | -81.8% | 0.73% | -56.0% | |
| ADMA | Sell | ADMA BIOLOGICS INC | $876,000 | -49.1% | 497,842 | -43.6% | 0.72% | -9.9% |
| XCUR | New | EXICURE INC | $601,000 | – | 275,848 | +100.0% | 0.49% | – |
| SIOX | New | SIO GENE THERAPIES INC | $537,000 | – | 205,900 | +100.0% | 0.44% | – |
| BAX | Sell | BAXTER INTL INC | $489,000 | -95.0% | 5,800 | -95.2% | 0.40% | -91.1% |
| ODT | New | ODONATE THERAPEUTICS INC | $402,000 | – | 117,621 | +100.0% | 0.33% | – |
| MORF | New | MORPHIC HLDG INC | $329,000 | – | 5,202 | +100.0% | 0.27% | – |
| ORGO | Sell | ORGANOGENESIS HLDGS INC | $278,000 | -98.2% | 15,232 | -99.2% | 0.23% | -96.8% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $260,000 | – | 56,500 | +100.0% | 0.21% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -174 | -100.0% | -0.01% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -8,942 | -100.0% | -0.02% | – |
| Exit | BEAM THERAPEUTICS INCput | $0 | – | -10,000 | -100.0% | -0.38% | – | |
| Exit | ARK ETF TRput | $0 | – | -10,000 | -100.0% | -0.43% | – | |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -125,654 | -100.0% | -0.46% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -60,250 | -100.0% | -0.49% | – |
| IMTX | Exit | IMMATICS N.V | $0 | – | -104,999 | -100.0% | -0.52% | – |
| Exit | ARENA PHARMACEUTICALS INCcall | $0 | – | -18,000 | -100.0% | -0.64% | – | |
| Exit | SPDR SER TRput | $0 | – | -10,000 | -100.0% | -0.65% | – | |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -12,112 | -100.0% | -0.69% | – |
| Exit | VERACYTE INCput | $0 | – | -35,000 | -100.0% | -0.79% | – | |
| QURE | Exit | UNIQURE NV | $0 | – | -53,900 | -100.0% | -0.90% | – |
| Exit | PROTHENA CORP PLCcall | $0 | – | -175,200 | -100.0% | -0.97% | – | |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -40,000 | -100.0% | -1.11% | – |
| MGLN | Exit | MAGELLAN HEALTH INC | $0 | – | -37,969 | -100.0% | -1.45% | – |
| Exit | TWIST BIOSCIENCE CORPput | $0 | – | -25,000 | -100.0% | -1.63% | – | |
| Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -40,000 | -100.0% | -2.89% | – | |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -420,514 | -100.0% | -3.62% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -41,418 | -100.0% | -3.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-01 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.